tiprankstipranks
Blurbs

Analysts’ Top Healthcare Picks: Replimune Group (REPL), Vaccitech Plc (VACC)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Replimune Group (REPLResearch Report) and Vaccitech Plc (VACCResearch Report) with bullish sentiments.

Replimune Group (REPL)

The company’s shares closed last Tuesday at $26.91, close to its 52-week high of $29.41.

According to TipRanks.com, Lawson is a 2-star analyst with an average return of 0.5% and a 41.4% success rate. Lawson covers the Healthcare sector, focusing on stocks such as Deciphera Pharmaceuticals, Arvinas Holding Company, and Blueprint Medicines.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Replimune Group with a $50.38 average price target.

See Insiders’ Hot Stocks on TipRanks >>

Vaccitech Plc (VACC)

According to TipRanks.com, Gould is a 2-star analyst with an average return of 1.1% and a 52.4% success rate. Gould covers the Healthcare sector, focusing on stocks such as Reata Pharmaceuticals, Applied Therapeutics, and Travere Therapeutics.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Vaccitech Plc with a $21.50 average price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on REPL:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles